TENX
TENX
NASDAQ · Biotechnology

Tenax Therapeutics Inc

$12.73
+0.37 (+2.99%)
As of Feb 8, 2:14 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +161.8% upside
Low Target $30.09
Average Target $33.33
High Target $42.13
Current Price $12.73
Current
$12.73
Target
$33.33
$30.09 $33.33 avg $42.13
Scenario Analysis
Bear Case
$30.09
136.4%
Low target
Base Case
$33.33
+161.8%
Avg target
Bull Case
$42.13
+231.0%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$38.36
-66.8% from high
52-Week Low
$28.57
+-55.4% from low
Target vs 52W High
$33.33
-13.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%